Pityriasis rosea
☆ Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
Pityriasis rosea ngasemva ― Iimacules ezingabonakaliyo kunye namabala, ngokungafaniyo nogqabhuko lwechiza oludla ngokurhawuzelelwa.
Ukuba irhawuzelelwa kakhulu, unokukrokrela isifo esifana ne- nummular eczema.
References
Pityriasis rosea yimeko yesikhumba yethutyana ephawulwe ngamabala aphakanyisiweyo kunye nezikali. Ngokuqhelekileyo iqala ngesiqwenga esinye, esibizwa ngokuba yi herald patch , ilandelwa ngamabala amaninzi avela kwiiveki ezimbalwa ezizayo. Nangona kunjalo, ayinguye wonke umntu onepityriasis rosea oya kuba nale patch yokuqala. Ezi ziqwenga zihlala zenza ipateni eyahlukileyo efana nomthi weKrismesi kwisiqu kunye namalungu aphezulu.
Pityriasis rosea, also known as pityriasis circinata, roseola annulata, and herpes tonsurans maculosus is an acute self-limiting papulosquamous disorder. It is often characterized by an initial herald patch, followed by scaly oval patches within 2 weeks. However, the herald patch is not always present. The scaly oval patches typically distribute in a Christmas-tree pattern on the trunk and proximal extremities. This activity reviews the evaluation and treatment of pityriasis rosea and the importance of the interprofessional team in recognizing and managing patients with this condition.
Pityriasis rosea, also known as pityriasis circinata, roseola annulata, and herpes tonsurans maculosus is an acute self-limiting papulosquamous disorder. It is often characterized by an initial herald patch, followed by scaly oval patches within 2 weeks. However, the herald patch is not always present. The scaly oval patches typically distribute in a Christmas-tree pattern on the trunk and proximal extremities. This activity reviews the evaluation and treatment of pityriasis rosea and the importance of the interprofessional team in recognizing and managing patients with this condition.
Pityriasis rosea yirhashalala eqhelekileyo edla ngokuqala ngesiqwenga esinye esiqwini kwaye isasazeke ukugquma isiqu kunye namalungu. Ukuxilongwa kuxhomekeke kuvavanyo lweklinikhi. Isiqwenga sokuqala sibonakala sibomvu kunye nomda ophakamileyo kunye neziko elitshisiweyo. Irhashalala ngokuqhelekileyo ivela kwiiveki ezimbini kamva. Izigulana zinokuba nokudinwa, isicaphucaphu, iintloko ezibuhlungu, iintlungu zamalungu, iilymph nodes ezidumbileyo, umkhuhlane, kunye nomqala obuhlungu ecaleni kwerhashalala. Iimeko ezifanayo ziquka i-syphilis, i-seborrheic dermatitis, i-eczema, kunye nezinye. Unyango lujolise ekunciphiseni iimpawu nge-corticosteroids okanye i-antihistamines. I-Acyclovir inokunceda kwezinye iimeko. Iimeko ezinzima zinokuzuza kwi-UV phototherapy. Isifo ngexesha lokukhulelwa ngamanye amaxesha siye sadibaniswa nokuphuphuma kwesisu.
Pityriasis rosea is a common rash that usually begins with a single patch on the trunk and spreads to cover the trunk and limbs. Diagnosis relies on clinical examination. The initial patch appears red with a raised border and sunken center. The rash typically emerges about two weeks later. Patients may experience fatigue, nausea, headaches, joint pain, swollen lymph nodes, fever, and sore throat alongside the rash. Similar conditions include syphilis, seborrheic dermatitis, eczema, and others. Treatment aims to alleviate symptoms with corticosteroids or antihistamines. Acyclovir may help in some cases. Severe instances may benefit from UV phototherapy. The disease during pregnancy sometimes has been linked to miscarriage.
Pityriasis rosea is a common rash that usually begins with a single patch on the trunk and spreads to cover the trunk and limbs. Diagnosis relies on clinical examination. The initial patch appears red with a raised border and sunken center. The rash typically emerges about two weeks later. Patients may experience fatigue, nausea, headaches, joint pain, swollen lymph nodes, fever, and sore throat alongside the rash. Similar conditions include syphilis, seborrheic dermatitis, eczema, and others. Treatment aims to alleviate symptoms with corticosteroids or antihistamines. Acyclovir may help in some cases. Severe instances may benefit from UV phototherapy. The disease during pregnancy sometimes has been linked to miscarriage.
In most cases, PR does not influence pregnancy or birth outcomes. Analysis of pooled data from our study and from previous studies revealed that the week of pregnancy at onset of PR was inversely associated with an unfavorable outcome (odds ratio [OR] = 0.937; 95 % CI 0.883 to 0.993). In addition, duration of PR (OR = 1.432; 95 % CI 1.129 to 1.827), additional extracutaneous symptoms (OR = 4.112; 95 % CI 1.580 to 10.23), and widespread rash distribution (OR 5.203, 95 % CI 1.702 to 14.89) were directly associated with unfavorable outcome.
Pityriasis rosea sisimo solusu esixhaphakileyo esichaphazela abantu abafikisayo kunye nabantu abadala abasebatsha (abaneminyaka eyi-10-35) , kancinci ngakumbi kwabasetyhini. Iqala ngesiquphe, ngesiqhelo ngesiziba esinye esaziwa njenge Herald patch esiqwini, ilandelwe yirhashalala yamabala amancinci, apinkish ombhoxo arhangqwe yiringi engwevu. La mabala akholisa ukwenza ipateni efana ne Christmas tree esiqwini. Irhashalala idla ngokuhlala malunga neeveki ezi-6 ukuya kwezisi-8. Pityriasis rosea ichaphazela malunga ne-0. 68% yabantu ababona i-dermatologist, kodwa oku kunokwahluka kwi-0. 39% ukuya kwi-4. 8%.
Pityriasis rosea (PR) is a relatively common, self-limited papulo-squamous dermatosis of unknown origin, which mainly appears in adolescents and young adults (10-35 years), slightly more common in females. It has a sudden onset, and in its typical presentation, the eruption is preceeded by a solitary patch termed “herald patch”, mainly located on the trunk. Few days later, a secondary eruption appears, with little pink, oval macules, with a grayish peripheral scaling collarette around them. The secondary lesions adopt a characteristic distribution along the cleavage lines of the trunk, with a configuration of a “Christmas tree”. In most cases, the eruption lasts for 6 to 8 wk. Its incidence has been estimated to be 0.68% of dermatologic patients, varying from 0.39% to 4.8%.
Pityriasis rosea (PR) is a relatively common, self-limited papulo-squamous dermatosis of unknown origin, which mainly appears in adolescents and young adults (10-35 years), slightly more common in females. It has a sudden onset, and in its typical presentation, the eruption is preceeded by a solitary patch termed “herald patch”, mainly located on the trunk. Few days later, a secondary eruption appears, with little pink, oval macules, with a grayish peripheral scaling collarette around them. The secondary lesions adopt a characteristic distribution along the cleavage lines of the trunk, with a configuration of a “Christmas tree”. In most cases, the eruption lasts for 6 to 8 wk. Its incidence has been estimated to be 0.68% of dermatologic patients, varying from 0.39% to 4.8%.
Nangona isizathu singacacanga ngokupheleleyo, kukholelwa ukuba inxulumene ne-herpesvirus yabantu 6 okanye i-herpesvirus yabantu 7. Akubonakali ukuba iyosulela. Amayeza athile anokukhokelela kwirhashalala efanayo. Uxilongo lusekelwe kwiimpawu kwaye i-biopsy ayisoloko iyimfuneko.
Njengesifo esiqhelekileyo, malunga ne-1.3% yabantu abachaphazelekayo ngexesha elithile. Idla ngokubakho kwabo baphakathi kweminyaka eli-10 nama-35 ubudala.
○ Uxilongo kunye noNyango
Ukuba iqhubeka ngaphezu kwenyanga eyi-1, umsebenzi ocacileyo unokufuneka ukuba uhluke kwezinye izifo (parapsoriasis, syphilis).
#Phototherapy
#OTC steroid ointment